Inadvertent postdialysis anticoagulation due to heparin line locks

Hemodialysis International

Volumn 11, Issue 4, 2007, Pages 430-434

  Pepper, Ruth J ^a   Gale, Daniel P ^a   Wajed, Julekha ^a   Bommayya, Girish ^a   Ashby, Damien ^a   McLean, Adam ^a   Laffan, Mike ^a   Maxwell, Patrick H ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Hemodialysis; Heparin; Line locks; Venous catheters

Indexed keywords

CITRIC ACID; HEPARIN;

ARTERIOVENOUS FISTULA; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD SAMPLING; BOLUS INJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; IN VITRO STUDY; INDWELLING CATHETER; PARTIAL THROMBOPLASTIN TIME; RISK REDUCTION;

ANTICOAGULANTS; ARTERIOVENOUS FISTULA; BLOOD COAGULATION DISORDERS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FACTOR XA; HEPARIN; HUMANS; PARTIAL THROMBOPLASTIN TIME; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 35148867905     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2007.00213.x     Document Type: Article

References (12)

1. NKF-K/DOQI clinical practice guidelines for vascular access: Update 2000. Am J Kidney Dis. 2001; 37: S137-S181.
2. Lohr JW, Schwab SJ. Minimizing hemorrhagic complications in dialysis patients. J Am Soc Nephrol. 1991; 2: 961-975.
3. Harenberg J, Haaf B, Dempfle CE, Stehle G, Heene DL. Monitoring of heparins in hemodialysis using an anti-factor-Xa-specific whole-blood clotting assay. Nephrol Dial Transplant. 1995; 10: 217-222.
4. McGill RL, Blas A, Bialkin S, Sandroni SE, Marcus RJ. Clinical consequences of heparin-free hemodialysis. Hemodial Int. 2005; 9: 393-398.
5. Bayés B, Bonal J, Romero R. Sodium citrate lock for filling hemodialysis catheters. Nephrol Dial Transplant. 1999; 14: 2532-2533.
6. Agharazii M, Plamondon I, Lebel M, Douville P, Desmeules S. Estimation of heparin into the systemic circulation after central venous catheter heparin lock. Nephrol Dial Transplant. 2005; 20: 1238-1240.
7. Vorweg M, Monaca E, Doehn M, Wappler F. The "heparin lock:" Cause for iatrogenic coagulopathy. Eur J Anaesthesiol. 2006; 23: 50-53.
8. Karaaslan H, Peyronnet P, Benevent D, et al. Risk of heparin lock related bleeding when using indwelling venous catheter in hemodialysis. Nephrol Dial Transplant. 2001; 16: 2072-2074.
9. Barzu T, Molho P, Tobelem G, et al. Binding and endocytosis of heparin by human endothelial cells in culture. Biochem Biophys Acta. 1985; 845: 196-203.
10. Dawes J, Pepper DS. Catabolism of low-dose heparin in man. Thromb Res. 1979; 14: 845-860.
11. de Swart CA, Nijmeyer B, Roelofs JM, Sixma JJ. Kinetics of intravenously administered heparin in normal humans. Blood. 1982; 60: 1251-1258.
12. Stas KJ, Vanwalleghem J, De Moor BD, et al. Trisodium citrate 30% vs. heparin 5% as catheter lock in the interdialytic period in twin- or double-lumen dialysis catheter for intermittent hemodialysis. Nephrol Dial Transplant. 2001; 16: 1521-1522.